World-Class Management Team


Dr. Olga Kubassova, PhD
Chief Executive Officer
Life Science Innovator, Venture Partner and Bio-Pharma Drug Development Strategist

Chief Excecutive Officer of IAG, with expertise in actively managing innovation in life science companies, asset positioning, strategy and capital.

Jan Lundberg_TB Alliance Board of Directors
Dr. Jan Lundberg, MD, PhD
Chair of Scientifc Advisory Board
Novel Drug Discovery and Development

Chair of IAG’s Scientifc Advisory Board and expert in global pharmaceutical R&D, developing treatments in immunology, neurology and oncology.

Dr. Jamshid Dehmeshki, PhD
Chief Technology Officer
Expert in Imaging, AI and Machine Learning in Drug Development

IAG’s Chief Technology Officer and AI Professor, recognized expert in imaging strategies and artificial intelligence to optimize data management and data analytics.

Christophe Berthoux, MD
Biotech and Pharma Drug Development Strategy

Chairman of IAG and operating partner of ArchiMed, recognized commercial leader in clinical research sector, investor and strategist.

Michael Clark, PMP
Chief Operating Officer
Building Teams and Scalling Capabilities to Deliver Global Scale Imaging Clinical Trials

IAG’s COO and drug development veteran with 20+ years of experience growing teams and scaling operations.

Robert Karl
Investment Director / Bio-Partnering
Investment Strategy and Capital for Life-Sciences Companies

Robert is heavily involved into building a diversified investment portfolio composed of early to market stage products.

Richard Barker, OBE
Scientific Advisor

Member of IAG’s Scientific Advisory Board, NED and lead in precision medicine clinical research.

Marci Newnham
Account Director, Business Development
Sales and Business Development Professional within the Life Sciences industry.

IAG’s Account Director with 13+ years Sales and Business Development experience within the Life Sciences industry.